Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

SARS-CoV-2, Trait Anxiety, and the Microbiome

P. Büttiker, S. Weissenberger, GB. Stefano, RM. Kream, R. Ptacek

. 2021 ; 12 (-) : 720082. [pub] 20210908

Language English Country Switzerland

Document type Journal Article, Review

During the COVID-19 pandemic, research on the relationships between the virus and its human host has become fundamental to understand this pathology and its effects. Attaining this profound understanding is critical for the effective containment and treatment of infections caused by the virus. In this review, we present some possible mechanisms by which psychopathological symptoms emerge following viral infections of the central nervous system (CNS). These proposed mechanisms are based on microbial communication and the induced priming of microglial antibody activation within the CNS through Toll-like receptor signaling. In this process, chronic microglial activation causes increased glutamate release in virally-altered, high-density neuronal structures, thereby modulating cognitive networks and information integration processes. This modulation, in turn, we suggest, affects the accuracy of sensory integration and connectivity of major control networks, such as the default mode network. The chronic activation of immunological responses and neurochemical shifts toward an elevated glutamate/gamma-aminobutyric acid ratio lead to negative reinforcement learning and suboptimal organismic functioning, for example, maintaining the body in an anxious state, which can later become internalized as trait anxiety. Therefore, we hypothesize that the homeostatic relationship between host, microbiome, and virome, would be decisive in determining the efficiency of subsequent immunological responses, disease susceptibility, and long-term psychopathological effects of diseases that impact the CNS, such as the COVID-19.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21023979
003      
CZ-PrNML
005      
20211013134104.0
007      
ta
008      
211006s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fpsyt.2021.720082 $2 doi
035    __
$a (PubMed)34566721
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Büttiker, Pascal $u First Faculty of Medicine, Center for Cognitive and Molecular Neuroscience, Charles University in Prague, Prague, Czechia
245    10
$a SARS-CoV-2, Trait Anxiety, and the Microbiome / $c P. Büttiker, S. Weissenberger, GB. Stefano, RM. Kream, R. Ptacek
520    9_
$a During the COVID-19 pandemic, research on the relationships between the virus and its human host has become fundamental to understand this pathology and its effects. Attaining this profound understanding is critical for the effective containment and treatment of infections caused by the virus. In this review, we present some possible mechanisms by which psychopathological symptoms emerge following viral infections of the central nervous system (CNS). These proposed mechanisms are based on microbial communication and the induced priming of microglial antibody activation within the CNS through Toll-like receptor signaling. In this process, chronic microglial activation causes increased glutamate release in virally-altered, high-density neuronal structures, thereby modulating cognitive networks and information integration processes. This modulation, in turn, we suggest, affects the accuracy of sensory integration and connectivity of major control networks, such as the default mode network. The chronic activation of immunological responses and neurochemical shifts toward an elevated glutamate/gamma-aminobutyric acid ratio lead to negative reinforcement learning and suboptimal organismic functioning, for example, maintaining the body in an anxious state, which can later become internalized as trait anxiety. Therefore, we hypothesize that the homeostatic relationship between host, microbiome, and virome, would be decisive in determining the efficiency of subsequent immunological responses, disease susceptibility, and long-term psychopathological effects of diseases that impact the CNS, such as the COVID-19.
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Weissenberger, Simon $u First Faculty of Medicine, Center for Cognitive and Molecular Neuroscience, Charles University in Prague, Prague, Czechia $u Department of Psychology, University of New York in Prague, Prague, Czechia
700    1_
$a Stefano, George B $u First Faculty of Medicine, Center for Cognitive and Molecular Neuroscience, Charles University in Prague, Prague, Czechia
700    1_
$a Kream, Richard M $u First Faculty of Medicine, Center for Cognitive and Molecular Neuroscience, Charles University in Prague, Prague, Czechia
700    1_
$a Ptacek, Radek $u First Faculty of Medicine, Center for Cognitive and Molecular Neuroscience, Charles University in Prague, Prague, Czechia
773    0_
$w MED00174602 $t Frontiers in psychiatry $x 1664-0640 $g Roč. 12, č. - (2021), s. 720082
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34566721 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20211006 $b ABA008
991    __
$a 20211013134101 $b ABA008
999    __
$a ind $b bmc $g 1708152 $s 1144473
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 12 $c - $d 720082 $e 20210908 $i 1664-0640 $m Frontiers in psychiatry $n Front Psychiatry $x MED00174602
LZP    __
$a Pubmed-20211006

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...